OPEN Health and Pharmerit Combine the Best of Both Worlds
Discover where the next step in your career could take you.
Why Pharmerit and OPEN Health?
Together, we offer a truly comprehensive suite of services to identify and address evidence gaps and deliver world class communications across a wide range of media. Combined with our broad scope of therapeutic expertise, we produce results and solutions that are of the highest quality.
What We Do
Our multidisciplinary teams work across 4 Centers of Excellence to communicate a product’s value.
Latest News and Views
The Proper Order of Things is Often A Mystery: A Novel Approach to Selecting Treatment Sequences
Watch the recording of the ISPOR webinar
Market Access in 2021 and Beyond: Reflections on Virtual ISPOR Europe 2020
Market Access in 2021 and Beyond: Reflections on Virtual ISPOR Europe 2020
Into the QOL-verse: A Reflection on Quality of Life Valuation Origin Stories
Just a few musings before ISOQOL from your friendly neighborhood researcher.
Solving pharma’s biggest challenges
People are at the heart of our business. Without our incredibly talented people, we couldn’t offer our clients the world-class service they have come to expect.
We know how important it is to support, develop, reward and encourage our team. And that’s just part of what makes Pharmerit – an OPEN Health Company a great place to work.
Latest News
Direct Medical Costs Associated With Treatment Nonpersistence in Patients With Higher-Risk Myelodysplastic Syndromes Receiving Hypomethylating Agents: A Large Retrospective Cohort Analysis
Direct Medical Costs Associated With Treatment Nonpersistence in
Mortality Prediction of the CHA 2 DS 2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
Mortality Prediction of the CHA 2 DS 2-VASc
Under-use of Hypomethylating Agents in Patients With Higher-risk Myelodysplastic Syndrome in the United States: A Large Population-based Analysis
Under-use of Hypomethylating Agents in Patients With Higher-risk
